Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)

Health and Quality of Life Outcomes

Volumn 7, Issue , 2009, Pages

  Ramp, Melina ^a   Khan, Fary ^a   Misajon, Rose Anne ^b   Pallant, Julie F ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANXIETY; ARTICLE; ATTITUDE TO ILLNESS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERNAL VALIDITY; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MULTIPLE SCLEROSIS; PATIENT ATTITUDE; PERSONAL HYGIENE; PHYSICAL CAPACITY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; RASCH ANALYSIS; RATING SCALE; SELF ESTEEM; SEX DIFFERENCE; TASK PERFORMANCE; TERTIARY HEALTH CARE; AUSTRALIA; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; QUESTIONNAIRE; REPRODUCIBILITY; STANDARD; VALIDATION STUDY;

ADULT; AGED; AUSTRALIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 67650751781     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-7-58     Document Type: Article

References (38)

1. Atlas: Country Resources for Neurological Disorders http://www.who.int/ mental_health/neurology/neurogy_atlas_lr.pdf
2. Mitchell AJ Benito-Leon J Gonzalez J-MM Rivera-Navarro J Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing Lancet Neurol 2005, 4(9):556-566. 10.1016/S1474-4422(05)70166-6 16109362
3. Keegan BM Noseworthy JH Multiple Sclerosis Annu Rev Med 2002, 53:285-302. 10.1146/annurev.med.53.082901.103909 11818475
4. Ford HL Gerry E Tennant A Whalley D Haigh R Johnson ME Developing a disease-specific quality of life measure for people with multiple sclerosis Clin Rehabil 2001, 15(3):247-258. 10.1191/026921501673658108 11386394
5. Khan F McPhail T Brand C Turner-Stokes L Kilpatrick T Multiple sclerosis: Disability profile and quality of life in an Australian community cohort Int J Rehabil Res 2006, 29(2):87-96. 10.1097/ 01.mrr.0000194393.56772.62 16609318
6. Khan F Pallant J Chronic pain in multiple sclerosis: Prevalence, characteristics, and impact on quality of life in an Australian community cohort J Pain 2007, 8(8):614-623. 10.1016/j.jpain.2007.03.005 17543586
7. Khan F Pallant J Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis Disabil Rehabil 2007, 29(3):205-213. 10.1080/09638280600756141 17364771
8. Khan F Pallant J Brand C Kilpatrick T Effectiveness of rehabilitation intervention in persons with multiple sclerosis: A randomized controlled trial J Neurol Neurosurg Psychiatry 2008, 79(11):1230-5. 10.1136/ jnnp.2007.133777 18535027
9. Khan F Turner-Stokes L Ng L Kilpatrick T Multidisciplinary rehabilitation for adults with multiple sclerosis (Review) Cochrane Database Syst Rev. 2007, 18:2. CD006036
10. Kurtzke J Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) Neurology 1983, 33:1444-1452. 6685237
11. Vickrey BG Hays RD Harooni R Myers LW Ellison GW A health-related quality of life measure for multiple sclerosis Qual Life Res 1995, 4(3):187-206. 10.1007/BF02260859 7613530
12. LaRocca NG Ritvo PG Miller DM Fischer JS Andrews H Paty DW 'Quality of life' assessment in multiple sclerosis clinical trials: Current status and strategies for improving multiple sclerosis clinical trial design Multiple sclerosis: Advances in clinical trial design, treatment and future perspectives London: Springer-Verlag Goodkin DE, Rudick RA 1996:145-160.
13. Cella DF Dineen K Arnason B Reder A Webster KA Karabatsos G Chang C Lloyd S Mo F Stewart J et al Validation of the functional assessment of multiple sclerosis quality of life instrument Neurology 1996, 47:129-139. 8710066
14. Rudick R Antel J Confavreux C Cutter G Ellison G Fisher J Lublin F Miller A Petkau J Rao S et al Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force Ann Neurol 1997, 42(3):379-382. 10.1002/ana.410420318 9307263
15. Sharrack B Hughes RA The Guy's Neurological Disability Scale (GNDS): A new disability measure for multiple sclerosis Mult Scler 1999, 5:223-233. 10467380
16. Pfennings LE Ploeg Van der HM Cohen L Bramsen I Polman CH Lankhorst GJ Vleugels L A health-related quality of life questionnaire for multiple sclerosis patients Acta Neurol Scand 1999, 100(3):148-155. 10478577
17. Hobart J Freeman J Lamping D Fitzpatrick R Thompson A The SF-36 in multiple sclerosis: Why basic assumptions must be tested J Neurol Neurosurg Psychiatry 2001, 71(3):363-370. 1737568 11511712 10.1136/ jnnp.71.3.363
18. Hobart J Lamping D Fitzpatrick R Riazi A Thompson A The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient-based outcome measure Brain 2001, 124:962-973. 10.1093/brain/124.5.962 11335698
19. Riazi A Hobart J Lamping D Fitzpatrick R Thompson A Multiple Sclerosis Impact Scale (MSIS-29): Reliability and validity in hospital based samples J Neurol Neurosurg Psychiatry 2002, 73(6):701-704. 1757371 12438473 10.1136/jnnp.73.6.701
20. Costelloe L O'Rourke K Kearney H McGuigan C Gribbin L Duggan M Daly L Tubridy N Hutchinson M The patient knows best: Significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical) J Neurol Neurosurg Psychiatry 2007, 78:841-844. 10.1136/ jnnp.2006.105759 17332049
21. Riazi A Hobart J Lamping D Fitzpatrick R Thompson A Evidence-based measurement in multiple sclerosis: The psychometric properties of the physical and psychological dimensions of three quality of life rating scales Mult Scler 2003, 9:411-419. 10.1191/1352458503ms929oa 12926848
22. Hoogervorst E Zwemmer J Jelles B Polman C Uitdehaag B Multiple Sclerosis Impact Scale (MSIS-29): Relation to established measures of impairment and disability Mult Scler 2004, 10:569-574. 10.1191/1352458504ms1078oa 15471375
23. McGuigan C Hutchinson M The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure J Neurol Neurosurg Psychiatry 2004, 75(2):266-269. 1738881 14742602
24. Hobart J Riazi A Lamping D Fitzpatrick R Thompson A How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales J Neurol Neurosurg Psychiatry 2005, 76(11):1539-1543. 1739386 16227547 10.1136/jnnp.2005.064584
25. Ayatollahi P Nafissi S Eshraghian MR Kaviani H Tarazi A Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis Mult Scler 2007, 13:275-277. 10.1177/1352458506070960 17439899
26. van der Linden FAH Kragt JJ Hobart JC Klein M Thompson AJ van der Ploeg HM Polman CH Uitdehaag BMJ Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life J Neurol Neurosurg Psychiatry 2006, 77(10):1157-1162. 10.1136/jnnp.2006.090795 16820417
27. Rasch G Probabilistic models for some intelligence and attainment tests Chicago: The University of Chicago Press 1960 Expanded edn
28. Tennant A McKenna SP Hagell P Application of Rasch Analysis in the Development and Application of Quality of Life Instruments Value Health 2004:S22-S26. 10.1111/j.1524-4733.2004.7s106.x 15367240
29. Bond TG Fox CM Applying the Rasch model: Fundamental measurement in the human sciences Mahwah, New Jersey: Lawrence Erlbaum Associates 2001.
30. DeVellis RF Scale development: Theory and applications Thousand Oaks, CA: Sage Publications 2 2003.
31. Pallant JF Tennant A An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS) Br J Clin Psychol 2007, 46(1):1-18. 10.1348/014466506X96931 17472198
32. McDonald WI Compston A Edan G Goodkin D Hartung HP Lublin FD McFarland HF Paty DW Polman CH Reingold SC Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 2001, 50(10):121-127. 10.1002/ ana.1032 11456302
33. Andrich D Lyne A Sheridan B Luo G Rasch Unidimensional Measurement Models (RUMM2020 Version 4.0) Duncraig, Western Australia: Rumm Laboratory Pty Ltd 2003.
34. Tennant A Conaghan PG The Rasch Measurement Model in Rheumatology: What is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 2007, 57(8):1358-1362. 10.1002/art.23108 18050173
35. Smith EV Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals Journal of Applied Measurement 2002, 3:205-231. 12011501
36. Tennant A Pallant J Unidimensionality matters! (A tale of two Smiths?) Rasch Measurement Transactions 2006, 20(1):1048-1051.
37. Linacre JM Sample size and item calibration stability Rasch Measurement Transactions 1994, 7(4):328.
38. SPSS SPSS Version 14.0 SPSS Inc 2005.